{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:25:33Z","timestamp":1791588333843,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,13]],"date-time":"2018-01-13T00:00:00Z","timestamp":1515801600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00784-017-2325-6","type":"journal-article","created":{"date-parts":[[2018,1,13]],"date-time":"2018-01-13T07:33:13Z","timestamp":1515828793000},"page":"597-615","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol"],"prefix":"10.1007","volume":"22","author":[{"given":"Luca","family":"Ramaglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Guida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Iorio-Siciliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cuozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Sculean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,13]]},"reference":[{"issue":"10","key":"2325_CR1","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/j.jorganchem.2004.09.069","volume":"690","author":"JR Green","year":"2005","unstructured":"Green JR (2005) Zoledronic acid: pharmacologic profile of a potent bisphosphonate. J Organomet Chem 690(10):2439\u20132448. \n                    https:\/\/doi.org\/10.1016\/j.jorganchem.2004.09.069","journal-title":"J Organomet Chem"},{"issue":"5","key":"2325_CR2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00520-005-0913-5","volume":"14","author":"JJ Body","year":"2006","unstructured":"Body JJ (2006) Bisphosphonates for malignancy-related bone disease: current status, future developments. Support Care Cancer 14(5):408\u2013418. \n                    https:\/\/doi.org\/10.1007\/s00520-005-0913-5","journal-title":"Support Care Cancer"},{"issue":"12 supplement","key":"2325_CR3","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","volume":"88","author":"MJ Roger","year":"2000","unstructured":"Roger MJ, Gordon S, Benford HL (2000) Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88(12 supplement):2961\u20132978","journal-title":"Cancer"},{"key":"2325_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.canlet.2007.07.007","volume":"257","author":"V Stresing","year":"2007","unstructured":"Stresing V, Daubin\u00e9 F, Benzaid I (2007) Bisphosphonates in cancer therapy. Cancer Lett 257:16\u201335","journal-title":"Cancer Lett"},{"key":"2325_CR5","first-page":"1080","volume":"8","author":"D Santini","year":"2002","unstructured":"Santini D, Vincenzi B, Avvisati G (2002) Pamidronate induces modifications of circulating angiogenetic factors in cancer patients. Clin Cancer Res 8:1080\u20131084","journal-title":"Clin Cancer Res"},{"key":"2325_CR6","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Letter to the editor. J Oral Maxillofac Surg 61:1115\u20131118","journal-title":"J Oral Maxillofac Surg"},{"key":"2325_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","volume":"62","author":"SL Ruggiero","year":"2004","unstructured":"Ruggiero SL, Mehrotra B, Rosenberg TJ (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527\u2013534","journal-title":"J Oral Maxillofac Surg"},{"key":"2325_CR8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.joms.2005.01.010","volume":"63","author":"JW Hellstein","year":"2005","unstructured":"Hellstein JW, Marek CL (2005) Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 63:682\u2013689","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"2325_CR9","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","volume":"68","author":"TL Aghaloo","year":"2010","unstructured":"Aghaloo TL, Felsenfeld AL, Tetradis S (2010) Osteonecrosis of the jaw in a patient on denosumab. J Oral Maxillofac Surg 68(5):959\u2013963. \n                    https:\/\/doi.org\/10.1016\/j.joms.2009.10.010","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"2325_CR10","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update. J Oral Maxillofac Surg 72(10):1938\u20131956. \n                    https:\/\/doi.org\/10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Surg"},{"key":"2325_CR11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.oooo.2015.07.017","volume":"120","author":"T Min You","year":"2015","unstructured":"Min You T, Lee KH, Lee SH (2015) Denosumab-related osteonecrosis of the jaw: a case report and management based on pharmacokinetics. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 120:548\u2013553","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2325_CR12","doi-asserted-by":"publisher","first-page":"E32","DOI":"10.1016\/j.oooo.2013.02.001","volume":"115","author":"AR Santos-Silva","year":"2013","unstructured":"Santos-Silva AR, Belizario Rosa GA, Castro GD (2013) Osteonecrosis of the mandible associated with bevacizumab therapy. Oral Surg Oral Med Oral Pathol Oral Radiol 115:E32\u2013E36","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2325_CR13","first-page":"385","volume":"13","author":"L Ram\u00edrez","year":"2015","unstructured":"Ram\u00edrez L, L\u00f3pez RM, Casa\u00f1as E (2015) New non-bisphosphonate drugs that produce osteonecrosis of the jaws. Oral Health Prev Dent 13:385\u2013393","journal-title":"Oral Health Prev Dent"},{"issue":"1","key":"2325_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bone.2008.08.132","volume":"44","author":"A Brunello","year":"2009","unstructured":"Brunello A, Saia G, Bedogni A (2009) Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma. Bone 44(1):173\u2013175. \n                    https:\/\/doi.org\/10.1016\/j.bone.2008.08.132","journal-title":"Bone"},{"issue":"10","key":"2325_CR15","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1600-0714.2005.00351.x","volume":"34","author":"E Merigo","year":"2005","unstructured":"Merigo E, Manfredi M, Meleti M (2005) Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report. J Oral Pathol Med 34(10):613\u2013617. \n                    https:\/\/doi.org\/10.1111\/j.1600-0714.2005.00351.x","journal-title":"J Oral Pathol Med"},{"issue":"6","key":"2325_CR16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S1470-2045(06)70726-4","volume":"7","author":"CA Migliorati","year":"2006","unstructured":"Migliorati CA, Siegel MA, Elting LS (2006) Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol 7(6):508\u2013514. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(06)70726-4","journal-title":"Lancet Oncol"},{"issue":"1","key":"2325_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.surge.2011.09.002","volume":"10","author":"NMH McLeod","year":"2012","unstructured":"McLeod NMH, Brennan PA, Ruggiero SL (2012) Bisphosphonate osteonecrosis of the jaw: a historical and contemporary review. Surgeon 10(1):36\u201342. \n                    https:\/\/doi.org\/10.1016\/j.surge.2011.09.002","journal-title":"Surgeon"},{"key":"2325_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jcms.2011.05.003","volume":"40","author":"S Otto","year":"2012","unstructured":"Otto S, Schreyer C, Hafner S (2012) Bisphosphonate-related osteonecrosis of the jaws\u2014characteristics, risk factors, clinical features, localization and impact on oncological treatment. J Craniomaxillofac Surg 40:303\u2013309","journal-title":"J Craniomaxillofac Surg"},{"issue":"6","key":"2325_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1563\/1548-1336(2007)33[371:UOPPIT]2.0.CO;2","volume":"33","author":"CY Lee","year":"2007","unstructured":"Lee CY, David T, Nishime M (2007) Use of platelet-rich plasma in the management of oral bisphosphonate-associated osteonecrosis of the jaw: a report of 2 cases. J Oral Implantol 33(6):371\u2013382","journal-title":"J Oral Implantol"},{"key":"2325_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0278-2391(09)01877-1","volume":"67","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Dodson TB, Leon A (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw\u20142009 update. J Oral Maxillofac Surg 67:2\u201312","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"2325_CR21","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetziaff J (2009) The PRISMA statement for reporting systematic and meta-analysis of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10):e1\u2013e34. \n                    https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.006","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"2325_CR22","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.3324\/haematol.11096","volume":"92","author":"MT Petrucci","year":"2007","unstructured":"Petrucci MT, Gallucci C, Agrillo A (2007) Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients. Haematologica 92(9):1289\u20131290. \n                    https:\/\/doi.org\/10.3324\/haematol.11096","journal-title":"Haematologica"},{"key":"2325_CR23","first-page":"E770","volume":"13","author":"S Bocanegra-P\u00e8rez","year":"2008","unstructured":"Bocanegra-P\u00e8rez S, Barrero MV, Hern\u00e1ndez MS (2008) Bisphosphonate-associated osteonecrosis of the jaw. A proposal for conservative treatment. Med Oral Patol Oral Cir Bucal 13:E770\u2013E773","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"2325_CR24","first-page":"1741","volume":"16","author":"A Agrillo","year":"2012","unstructured":"Agrillo A, Filiaci F, Ramieri V (2012) Bisphosphonate-related osteonecrosis of the jaw (BRONJ) 5 year experience in the treatment of 131 cases with ozone therapy. Eur Rev Med Pharmacol Sci 16:1741\u20131747","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"2325_CR25","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jcms.2013.05.038","volume":"41","author":"S Otto","year":"2013","unstructured":"Otto S, Baumann S, Ehrenfeld M (2013) Successful surgical management of osteonecrosis of the jaw due to RANK-ligand inhibitor treatment using fluorescence guided bone resection. J Craniomaxillofac Surg 41(7):694\u2013698. \n                    https:\/\/doi.org\/10.1016\/j.jcms.2013.05.038","journal-title":"J Craniomaxillofac Surg"},{"issue":"2","key":"2325_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/scd.12023","volume":"34","author":"LF Duarte","year":"2014","unstructured":"Duarte LF, Reis HB, Tucci R (2014) Bisphosphonate-related osteonecrosis of the jaws: analysis of a case series at a dental school. Spec Care Dentist 34(2):77\u201383. \n                    https:\/\/doi.org\/10.1111\/scd.12023","journal-title":"Spec Care Dentist"},{"issue":"2","key":"2325_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2217\/fon.13.211","volume":"10","author":"G Campisi","year":"2014","unstructured":"Campisi G, Fedele S, Fusco V (2014) Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents. Future Oncol 10(2):257\u2013275. \n                    https:\/\/doi.org\/10.2217\/fon.13.211","journal-title":"Future Oncol"},{"issue":"8","key":"2325_CR28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1089\/pho.2014.3742","volume":"32","author":"MA Altay","year":"2014","unstructured":"Altay MA, Tasar F, Tosun E (2014) Low-level laser therapy supported surgical treatment of bisphosphonate related osteonecrosis of jaws: a retrospective analysis of 11 cases. Photomed Laser Surg 32(8):468\u2013475. \n                    https:\/\/doi.org\/10.1089\/pho.2014.3742","journal-title":"Photomed Laser Surg"},{"issue":"12","key":"2325_CR29","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.joms.2015.09.024","volume":"73","author":"SL Ruggiero","year":"2015","unstructured":"Ruggiero SL, Kohn N (2015) Disease stage and mode of therapy are important determinants of treatment outcomes for medication-related osteonecrosis of the jaw. J Oral Maxillofac Surg 73(12):S94\u2013S100. \n                    https:\/\/doi.org\/10.1016\/j.joms.2015.09.024","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"2325_CR30","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00198-007-0384-2","volume":"18","author":"N Yarom","year":"2007","unstructured":"Yarom N, Yahalom R, Shoshani Y (2007) Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome. Osteoporos Int 18(10):1363\u20131370. \n                    https:\/\/doi.org\/10.1007\/s00198-007-0384-2","journal-title":"Osteoporos Int"},{"key":"2325_CR31","first-page":"E267","volume":"12","author":"H Rinc\u00f3n","year":"2007","unstructured":"Rinc\u00f3n H, Rodr\u00edguez Z, Tambay C (2007) Osteonecrosis of the jaws and bisphosphonates. Report of fifteen cases. Therapeutic recommendations. Med Oral Patol Oral Cir Bucal 12:E267\u2013E271","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"2325_CR32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/annonc\/mdn630","volume":"20","author":"T Wyngaert Van den","year":"2009","unstructured":"Van den Wyngaert T, Claeys T, Huizing MT (2009) Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome. Ann Oncol 20:331\u2013336","journal-title":"Ann Oncol"},{"issue":"3","key":"2325_CR33","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1634\/theoncologist.2007-0159","volume":"13","author":"T Ibrahim","year":"2008","unstructured":"Ibrahim T, Barbanti F, Marrano GG (2008) Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: a retrospective study. Oncologist 13(3):330\u2013336. \n                    https:\/\/doi.org\/10.1634\/theoncologist.2007-0159","journal-title":"Oncologist"},{"issue":"3","key":"2325_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ijom.2009.11.014","volume":"39","author":"RA Williamson","year":"2010","unstructured":"Williamson RA (2010) Surgical management of bisphosphonate induced osteonecrosis of the jaws. Int J Oral Maxillofac Surg 39(3):251\u2013255. \n                    https:\/\/doi.org\/10.1016\/j.ijom.2009.11.014","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"1","key":"2325_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.tripleo.2010.02.020","volume":"110","author":"M Scoletta","year":"2010","unstructured":"Scoletta M, Arduino PG, Dalmasso P (2010) Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110(1):46\u201353. \n                    https:\/\/doi.org\/10.1016\/j.tripleo.2010.02.020","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"2325_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10103-009-0687-y","volume":"25","author":"P Vescovi","year":"2010","unstructured":"Vescovi P, Manfredi M, Merigo E (2010) Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT). Lasers Med Sci 25(1):101\u2013113. \n                    https:\/\/doi.org\/10.1007\/s10103-009-0687-y","journal-title":"Lasers Med Sci"},{"issue":"6","key":"2325_CR37","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.tripleo.2011.07.004","volume":"112","author":"F Moretti","year":"2011","unstructured":"Moretti F, Pelliccioni GA, Montebugnoli L (2011) A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112(6):777\u2013782. \n                    https:\/\/doi.org\/10.1016\/j.tripleo.2011.07.004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"6","key":"2325_CR38","first-page":"2313","volume":"31","author":"AM Eckardt","year":"2011","unstructured":"Eckardt AM, Lemound J, Lindhorst D (2011) Surgical management of bisphosphonate-related osteonecrosis of the jaw in oncologic patients\u2014a challenging problem. Anticancer Res 31(6):2313\u20132318","journal-title":"Anticancer Res"},{"key":"2325_CR39","doi-asserted-by":"publisher","first-page":"107690","DOI":"10.1155\/2014\/107690","volume":"2014","author":"P Vescovi","year":"2014","unstructured":"Vescovi P, Merigo E, Meleti M (2014) Conservative surgical management of stage I bisphosphonate-related osteonecrosis of the jaw. Int J Dent 2014:107690","journal-title":"Int J Dent"},{"issue":"1","key":"2325_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/2231-0746.161067","volume":"5","author":"Y Fukushima","year":"2015","unstructured":"Fukushima Y, Enoki Y, Nakaoka C (2015) Usability of surgical treatment in cases of bisphosphonate-related osteonecrosis of the jaw stage 2 with sequestrum. Ann Maxillofac Surg 5(1):67\u201370. \n                    https:\/\/doi.org\/10.4103\/2231-0746.161067","journal-title":"Ann Maxillofac Surg"},{"issue":"7","key":"2325_CR41","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jcms.2015.05.019","volume":"43","author":"JP Bodem","year":"2015","unstructured":"Bodem JP, Kargus S, Engel M (2015) Value of nonsurgical therapeutic management of stage I bisphosphonate-related osteonecrosis of the jaw. J Craniomaxillofac Surg 43(7):1139\u20131143. \n                    https:\/\/doi.org\/10.1016\/j.jcms.2015.05.019","journal-title":"J Craniomaxillofac Surg"},{"issue":"2","key":"2325_CR42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tripleo.2010.04.015","volume":"111","author":"F Wilde","year":"2011","unstructured":"Wilde F, Heufelder M, Winter K (2011) The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111(2):153\u2013163. \n                    https:\/\/doi.org\/10.1016\/j.tripleo.2010.04.015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"6","key":"2325_CR43","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s10103-011-0974-2","volume":"26","author":"B Atalay","year":"2011","unstructured":"Atalay B, Yalcin S, Emes Y (2011) Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery? Lasers Med Sci 26(6):815\u2013823. \n                    https:\/\/doi.org\/10.1007\/s10103-011-0974-2","journal-title":"Lasers Med Sci"},{"issue":"8","key":"2325_CR44","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jcms.2012.01.005","volume":"40","author":"PJ Voss","year":"2012","unstructured":"Voss PJ, Oshero JJ, M\u00fcller A (2012) Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients. J Craniomaxillofac Surg 40(8):719\u2013725. \n                    https:\/\/doi.org\/10.1016\/j.jcms.2012.01.005","journal-title":"J Craniomaxillofac Surg"},{"issue":"11","key":"2325_CR45","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.ijom.2012.05.012","volume":"41","author":"Z Jabbour","year":"2012","unstructured":"Jabbour Z, El-Hakim M, Mesbah-Ardakani P (2012) The outcomes of conservative and surgical treatment of stage 2 bisphosphonate-related osteonecrosis of the jaws: a case series. Int J Oral Maxillofac Surg 41(11):1404\u20131409. \n                    https:\/\/doi.org\/10.1016\/j.ijom.2012.05.012","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"5","key":"2325_CR46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bjoms.2011.08.004","volume":"50","author":"S Ferlito","year":"2012","unstructured":"Ferlito S, Puzzo S, Palermo F (2012) Treatment of bisphosphonate-related osteonecrosis of the jaws: presentation of a protocol and an observational longitudinal study of an Italian series of cases. Br J Oral Maxillofac Surg 50(5):425\u2013429. \n                    https:\/\/doi.org\/10.1016\/j.bjoms.2011.08.004","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"11","key":"2325_CR47","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.ijom.2012.04.020","volume":"41","author":"S Bocanegra-P\u00e8rez","year":"2012","unstructured":"Bocanegra-P\u00e8rez S, Vicente-Barrero M, Knezevic M (2012) Use of platelet-rich plasma in the treatment of bisphosphonate related osteonecrosis of the jaw. Int J Oral Maxillofac Surg 41(11):1410\u20131415. \n                    https:\/\/doi.org\/10.1016\/j.ijom.2012.04.020","journal-title":"Int J Oral Maxillofac Surg"},{"key":"2325_CR48","first-page":"011","volume":"S12","author":"M Mozzati","year":"2013","unstructured":"Mozzati M, Gallesio G, Pol R (2013) A report on a 7-year follow up of the surgical management with PRGF-ENDORET\u00ae of oncologic patients affected by intravenous bisphosphonate related osteonecrosis of the jaw. Surgery S12:011","journal-title":"Surgery"},{"issue":"9","key":"2325_CR49","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.bjoms.2014.07.256","volume":"52","author":"JW Kim","year":"2014","unstructured":"Kim JW, Kim SJ, Kim M (2014) Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study. Br J Oral Maxillofac Surg 52(9):854\u2013859. \n                    https:\/\/doi.org\/10.1016\/j.bjoms.2014.07.256","journal-title":"Br J Oral Maxillofac Surg"},{"key":"2325_CR50","doi-asserted-by":"publisher","unstructured":"Longo F, Guida A, Aversa C (2014) Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literature. Int J Dent Article ID 298945. \n                    https:\/\/doi.org\/10.1155\/2014\/298945","DOI":"10.1155\/2014\/298945"},{"issue":"6","key":"2325_CR51","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00784-014-1384-1","volume":"19","author":"P Rugani","year":"2015","unstructured":"Rugani P, Acham S, Kirnbauer B (2015) Stage-related treatment concept of medication-related osteonecrosis of the jaw\u2014a case series. Clin Oral Investig 19(6):1329\u20131338. \n                    https:\/\/doi.org\/10.1007\/s00784-014-1384-1","journal-title":"Clin Oral Investig"},{"issue":"9","key":"2325_CR52","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.jcms.2015.07.035","volume":"43","author":"W Reich","year":"2015","unstructured":"Reich W, Bilkenroth U, Schubert J (2015) Surgical treatment of bisphosphonate-associated osteonecrosis: prognostic score and long-term results. J Craniomaxillofac Surg 43(9):1809\u20131822. \n                    https:\/\/doi.org\/10.1016\/j.jcms.2015.07.035","journal-title":"J Craniomaxillofac Surg"},{"issue":"7","key":"2325_CR53","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.joms.2015.01.008","volume":"73","author":"RN Lopes","year":"2015","unstructured":"Lopes RN, Rabelo GD, Rocha AC (2015) Surgical therapy for bisphosphonate-related osteonecrosis of the jaw: six year experience of a single institution. J Oral Maxillofac Surg 73(7):1288\u20131295. \n                    https:\/\/doi.org\/10.1016\/j.joms.2015.01.008","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"2325_CR54","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.oooo.2015.10.033","volume":"121","author":"JP Bodem","year":"2016","unstructured":"Bodem JP, Schaal C, Kargus S (2016) Surgical management of bisphosphonate-related osteonecrosis of the jaw stages II and III. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 121(4):367\u2013372. \n                    https:\/\/doi.org\/10.1016\/j.oooo.2015.10.033","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"8","key":"2325_CR55","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.bjoms.2016.06.015","volume":"54","author":"M Nisi","year":"2016","unstructured":"Nisi M, La Ferla F, Karapetsa D (2016) Conservative surgical management of patients with bisphosphonate-related osteonecrosis of the jaw: a series of 120 patients. Br J Oral Maxillofac Surg 54(8):930\u2013935. \n                    https:\/\/doi.org\/10.1016\/j.bjoms.2016.06.015","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"2","key":"2325_CR56","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.11607\/jomi.te61","volume":"29","author":"RE Marx","year":"2014","unstructured":"Marx RE (2014) A decade of bisphosphonate bone complications: what it has taught us about bone physiology. Int J Oral Maxillofac Implants 29(2):e247\u2013e258. \n                    https:\/\/doi.org\/10.11607\/jomi.te61","journal-title":"Int J Oral Maxillofac Implants"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-017-2325-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-017-2325-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-017-2325-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T07:24:36Z","timestamp":1547450676000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-017-2325-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,13]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["2325"],"URL":"https:\/\/doi.org\/10.1007\/s00784-017-2325-6","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,13]]},"assertion":[{"value":"12 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study (e.g., systematic review and meta-analysis), formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}